According to the report, the Global Circulating Tumor Cells Market was valued at USD 9.39 billion in 2017 and is expected to rise to a valuation of USD 28.3 billion by the end of 2023.
Market Research Future (MRFR) has announced a new release on the global circulating tumor cell market.
The report presents a detailed analysis of the market’s likely growth trajectory and drivers over the forecast period from 2018 to 2023, based on a solid examination of the CTC market’s growth over the past few years.
The clinical significance of circulating tumor cells was first recognized in 1869, but serious medical research within the context of the modern structure of the healthcare sector began in the 1990s.
These studies were inspired by calculations that showed that even small cancerous growths shedding cells at a small rate of less than 1% per day would produce enough circulating tumor cells in the bloodstream to be detectable.
Over 90% of the deaths caused by cancer are caused by cancers that have metastasized, leading to the field of circulating tumor cells taking on a highly important position in modern oncology.
Circulating Tumor Cells Market Analysis By Size, Share, Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2023
According to the report, the Global Circulating Tumor Cells Market was valued at USD 9.39 billion in 2017 and is expected to rise to a valuation of USD 28.3 billion by the end of 2023.
Market Research Future (MRFR) has announced a new release on the global circulating tumor cell market.
The report presents a detailed analysis of the market’s likely growth trajectory and drivers over the forecast period from 2018 to 2023, based on a solid examination of the CTC market’s growth over the past few years.
The clinical significance of circulating tumor cells was first recognized in 1869, but serious medical research within the context of the modern structure of the healthcare sector began in the 1990s.
These studies were inspired by calculations that showed that even small cancerous growths shedding cells at a small rate of less than 1% per day would produce enough circulating tumor cells in the bloodstream to be detectable.
Circulating Tumor Cell Diagnostics are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication.
Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients.
It includes enrichment, detection and analysis of the detected circulating tumor cells.
Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis.
CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancerKey questions addressed by the reportWhere will all these developments take Circulating Tumor Cell Diagnosticsin the mid- to long-term?What are the upcoming technological trends in the Circulating Tumor Cell Diagnosticsmarket?What are the opportunities for various players that exist at present and those that are planning to enter at different stages of the value chain?How growth strategies implemented by key players will impact the growth rate of the Circulating Tumor Cell Diagnosticsmarket, and who will have the undue advantage?What are the current adoption trends of the Circulating Tumor Cell Diagnosticsmarket?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-circulating-tumor-cell-diagnostics-2019-624Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells.
Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics.
Circulating Tumor Cell Market OverviewIn 2017, the global market size of circulating tumor cell (CTC) reached a valuation of USD 9,393.1 Mn.
The market is projected to surpass a valuation of USD 28,300 Mn by the end of 2023, reflecting a healthy growth rate.The prevalence rate of CTC has gone up in recent years.
The mechanism of CTC is responsible for a vast majority of deaths caused by cancer.
Circulating tumor cells can be associated with different types of cancer prognosis including breast cancer, prostate cancer, and gastric cancer among others.
Healthcare companies continue to focus on developing solutions that enable accurate and quick detection of CTC.
The diagnosis and analysis of CTCs can help in early cancer detection and determine appropriate treatments tailored for specific cancer types.The “Circulating Tumor Cell Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.The Circulating Tumor Cell Market provide valuable insight with an emphasis on the global market including some of the major players such As, Ikonisys Inc., Greiner Bio-One International GmbH, Thermo Fisher Scientific, SRI International, STEMCELL Technologies, Miltenyi Biotec, Menarini Silicon Biosystems, QIAGEN Hannover (QIAGEN), F. Hoffmann-La Roche Ltd, NanoString Technologies, Inc, Fluxion Biosciences, Inc., GE Healthcare, ApoCell, Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation), Epic Lifesciences, Celltraffix Inc.Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region.
